Print

Med BioGene Charged with Fraud, and Precision Therapeutics, Inc. Charged with Tortious Interference in Amended Complaint by Signal Genetics LLC  
2/25/2011 7:33:47 AM

NEW YORK--(BUSINESS WIRE)--Med Biogene Inc. (TSX Venture: MBI), a Vancouver-based life sciences company, has been charged with fraud, and Pittsburgh-based Precision Therapeutics, Inc., was charged with tortious interference in an amended complaint filed today by Signal Genetics in Supreme Court for the County of New York. On February 11, 2011, Signal filed a complaint charging Med Biogene with breach of agreement, violation of a confidentiality agreement and misuse of proprietary information, among other wrongdoings.